Evidence-Based Oncology | September

Evidence-Based Oncology

Michael E. Chernew, PhD; Lee N. Newcomer, MD, MHA; and Sandra M. Swain, MD; examine the treatment benefits, cost concerns, and insurance coverage strategies for pertuzumab.
Targeted Therapies to Further Improve Outcomes

Feature

$vacMongoViewPlus$